Filing Flows

Filing Flows › Companies › Bodhi Tree Biotechnology › Cash flow

Bodhi Tree Biotechnology cash flow, quarter by quarter

Latest: Q3 FY26 · from the cash-flow statements filed with the SEC

Free cash flow−$19K in Q3 FY26 · −$116K over twelve months

Operating cash flow−$19K
Free cash flow−$19K

Analysis

In Q3 FY26, Bodhi Tree Biotechnology generated −$19K of operating cash flow. That is $6K more than in Q3 FY25 (−$25K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$116K; the largest uses were operating cash flow ($116K); the cash balance fell by $116K.

Operating cash flow was −$19K against net income of −$23K. The largest differences: prepaid and other assets +$3K.

Free cash flow

Bodhi Tree Biotechnology: free cash flow by quarterBodhi Tree Biotechnology: free cash flow by quarter−$91KQ4 FY24−$65KQ1 FY25−$50KQ2 FY25−$25KQ3 FY25−$10KQ4 FY25−$62KQ1 FY26−$25KQ2 FY26−$19KQ3 FY26
Operating cash flow less capital spending.
Bodhi Tree Biotechnology: operating cash flow against capital spendingBodhi Tree Biotechnology: operating cash flow against capital spendingOperating cash flowCapital spending−$91K$0Q4 FY24−$65K$0Q1 FY25−$50K$0Q2 FY25−$25K$0Q3 FY25−$10K$0Q4 FY25−$62K$0Q1 FY26−$25K$0Q2 FY26−$19K$0Q3 FY26
Latest (Q3 FY26): Operating cash flow −$19K, Capital spending $0.

Cash runway and the debt wall

Cash & investments$4K
Debtnone
Net cash$4K
Cash runway0 months

Bodhi Tree Biotechnology is burning cash: its operations consume cash, a free cash flow of −$116K a year at the current rate against $4K of cash and investments: a runway of about 0 months before any new financing.

Where the cash came from and went

Bodhi Tree Biotechnology: sources (+) and uses (−) of cash, Q3 FY26Bodhi Tree Biotechnology: sources (+) and uses (−) of cash, Q3 FY26Operating cash flow−$19KCash drawn (+) / kept (−)$19K
Bodhi Tree Biotechnology: sources (+) and uses (−) of cash, TTM to Q3 FY26Bodhi Tree Biotechnology: sources (+) and uses (−) of cash, TTM to Q3 FY26Operating cash flow−$116KCash drawn (+) / kept (−)$116K

From profit to cash

Bodhi Tree Biotechnology: net income to operating cash flow, Q3 FY26Bodhi Tree Biotechnology: net income to operating cash flow, Q3 FY26Net income−$23KPrepaid and other assets$3KOperating cash flow−$19K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCash drawn (+) / kept (−)Free cash flow
Q3 FY26−$19K$19K−$19K
Q2 FY26−$25K$25K−$25K
Q1 FY26−$62K$62K−$62K
Q4 FY25−$10K$10K−$10K
Q3 FY25−$25K$25K−$25K
Q2 FY25−$50K$50K−$50K
Q1 FY25−$65K$65K−$65K
Q4 FY24−$91K−$190K−$91K

Bodhi Tree Biotechnology: income statement and cash flow

Bodhi Tree Biotechnology, Q3 FY26: revenue $10K, operating margin -232.0%. The chart follows the revenue to costs, profit and cash.

Bodhi Tree Biotechnology: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.